Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

  • Read more about Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

  • Read more about Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

  • Read more about Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients

  • Read more about Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

  • Read more about Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study

  • Read more about Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study

COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients

  • Read more about COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients

Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19

  • Read more about Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19

Use of a Hypochlorous Acid Spray Solution in the Treatment of COVID-19 Patients : COVICONTROL Study .

  • Read more about Use of a Hypochlorous Acid Spray Solution in the Treatment of COVID-19 Patients : COVICONTROL Study .

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

  • Read more about Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 199
  • Page 200
  • Page 201
  • Page 202
  • Current page 203
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA